Back to competency map

Clinical competency

Informed consent and experimental-treatment disclosure

Clearly explain the investigational nature of ibogaine treatment and its known serious risks before treatment begins. Ethical practice requires that patients understand both uncertain benefits and significant safety concerns.

Primary clinical guidelineModern clinical

Looking for something specific? Ask Blossom

Guidelines

1

Courses

0

Providers

0

Protocols

1

Classification

Protocol families

Ibogaine

Source quality

Protocol paper

Linked sources

The guidelines, courses, and providers that evidence this competency. Full lists are a Blossom Pro feature.

Linked guidelines (1)

  • Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study

    IbogaineEvidence score: 90
    Knuijver et al., 2021Source PDF

Unlock every linked source

See all linked guidelines, courses, and providers behind this competency, plus the full competency graph.

Unlock full depth